Cargando…

Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report

A 47-year-old man presented at the Ophthalmology Department of Saku City Asama General Hospital complaining of hyperemia and pain after industrial sodium hydroxide (approx. 40% concentration) had entered his left eye. With an epithelial defect of the bulbar and palpebral conjunctiva, ischemia of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Hidenori, Kokubun, Takamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342862/
https://www.ncbi.nlm.nih.gov/pubmed/25762927
http://dx.doi.org/10.1159/000369201
_version_ 1782359330597634048
author Sasaki, Hidenori
Kokubun, Takamichi
author_facet Sasaki, Hidenori
Kokubun, Takamichi
author_sort Sasaki, Hidenori
collection PubMed
description A 47-year-old man presented at the Ophthalmology Department of Saku City Asama General Hospital complaining of hyperemia and pain after industrial sodium hydroxide (approx. 40% concentration) had entered his left eye. With an epithelial defect of the bulbar and palpebral conjunctiva, ischemia of the inferior third of the limbal conjunctiva, a total corneal epithelial defect and mild corneal stromal opacity, the damage was determined as Roper-Hall grade III. 2% rebamipide ophthalmic suspension, which is used for dry eye disease, was administered 4 times a day followed by conventional treatment for serious alkali injury. The corneal epithelial defect was resolved, and there were no side effects. The effectiveness of 2% rebamipide ophthalmic suspension in both the repair and improvement of the damage in the conjunctival and corneal epithelia, and its anti-inflammatory effect suggest that it may be an effective treatment not only for dry eye disease but also for alkali ocular damage.
format Online
Article
Text
id pubmed-4342862
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-43428622015-03-11 Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report Sasaki, Hidenori Kokubun, Takamichi Case Rep Ophthalmol Published online: November, 2014 A 47-year-old man presented at the Ophthalmology Department of Saku City Asama General Hospital complaining of hyperemia and pain after industrial sodium hydroxide (approx. 40% concentration) had entered his left eye. With an epithelial defect of the bulbar and palpebral conjunctiva, ischemia of the inferior third of the limbal conjunctiva, a total corneal epithelial defect and mild corneal stromal opacity, the damage was determined as Roper-Hall grade III. 2% rebamipide ophthalmic suspension, which is used for dry eye disease, was administered 4 times a day followed by conventional treatment for serious alkali injury. The corneal epithelial defect was resolved, and there were no side effects. The effectiveness of 2% rebamipide ophthalmic suspension in both the repair and improvement of the damage in the conjunctival and corneal epithelia, and its anti-inflammatory effect suggest that it may be an effective treatment not only for dry eye disease but also for alkali ocular damage. S. Karger AG 2014-11-20 /pmc/articles/PMC4342862/ /pubmed/25762927 http://dx.doi.org/10.1159/000369201 Text en Copyright © 2014 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published online: November, 2014
Sasaki, Hidenori
Kokubun, Takamichi
Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report
title Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report
title_full Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report
title_fullStr Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report
title_full_unstemmed Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report
title_short Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report
title_sort alkali burn treated with 2% rebamipide ophthalmic suspension: a case report
topic Published online: November, 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342862/
https://www.ncbi.nlm.nih.gov/pubmed/25762927
http://dx.doi.org/10.1159/000369201
work_keys_str_mv AT sasakihidenori alkaliburntreatedwith2rebamipideophthalmicsuspensionacasereport
AT kokubuntakamichi alkaliburntreatedwith2rebamipideophthalmicsuspensionacasereport